2/20
11:49 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/20
11:49 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/12
08:22 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
01:17 pm
vrtx
Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord
Low
Report
Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord
2/11
12:15 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
12:15 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
09:57 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $480.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $480.00 price target on the stock.
2/11
09:53 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
09:53 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
09:53 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
09:39 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
09:39 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
08:09 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
2/11
08:09 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $550.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $550.00 price target on the stock.
2/11
07:29 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
07:29 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
07:03 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/11
07:03 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/31
12:42 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "outperform" rating re-affirmed by analysts at William Blair.
1/31
12:42 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "outperform" rating re-affirmed by analysts at William Blair.
1/31
10:50 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $480.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $480.00 price target on the stock.
1/31
10:34 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/31
09:51 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/31
09:51 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/31
08:09 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.